Page last updated: 2024-10-28

miltefosine and Lymphoma, B-Cell, Marginal Zone

miltefosine has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Lymphoma, B-Cell, Marginal Zone: Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vase, MØ1
Hellberg, YK1
Larsen, CS1
Petersen, E1
Schaumburg, H1
Bendix, K1
Ravel, C1
Bastien, P1
Christensen, M1
d'Amore, F1

Other Studies

1 other study available for miltefosine and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
    Acta haematologica, 2012, Volume: 128, Issue:1

    Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; HIV; HIV Infections; Humans; Immunophenotyping; K

2012